Syncom Formulations (India) is currently trading at Rs. 2.42, up by 0.02 points or 0.83% from its previous closing of Rs. 2.40 on the BSE.
The scrip opened at Rs. 2.45 and has touched a high and low of Rs. 2.45 and Rs. 2.35 respectively. So far 923747 shares were traded on the counter.
The BSE group 'XC' stock of face value Rs. 1 has touched a 52 week high of Rs. 10.03 on 05-Aug-2015 and a 52 week low of Rs. 2.09 on 29-Feb-2016.
Last one week high and low of the scrip stood at Rs. 2.70 and Rs. 2.33 respectively. The current market cap of the company is Rs. 188.92 crore.
The promoters holding in the company stood at 48.22% while Non-Institutions held 51.78% stake in the company.
Syncom Formulations (India) has purchased a property situated in Mumbai worth Rs 11 crore on April 20, 2016. The company has purchased property at office no F-401-402, 4th Floor, Lotus Corporate Park, Goregaon East, Mumbai in the state of Maharashtra. The office has super built up area of 9,000 square feet & carpet area of 5,489.64 square feet.
Syncom Formulations (India) is engaged in the business of pharmaceutical formulations. It manufactures range of products in various dosage forms and markets them in various countries.
